Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash on Highway 101 Near Mile Marker 16


SUV Goes Off Road, Hits Tree in Fatal Crescent City Accident

Fatal Accident 5

Crescent City, CA (January 13, 2020) – One person was killed in a solo-vehicle crash in Crescent City. The fatal accident occurred on the morning of January 13 on Highway 101.

A Suzuki SUV was heading north on Highway 101, near Mile Marker 16, when the driver lost control. The SUV went off the road, overturned and hit a large redwood tree.  The driver died at the accident scene.

 Our heartfelt condolences go out to the friends and loved ones of the victim.

#Crescent City

#95531


November 15, 2019

2 Injured in Multi-Vehicle Crash on Freedom Boulevard

Illegal U-Turn Causes Watsonville Accident...


March 23, 2020

2 Killed, 3 Injured in Crash at Belinda Circle and Lincoln Avenue

Vehicle Runs Red Light in Fatal Anaheim Accident...


December 16, 2019

Kevin Hart Killed in Crash on Interstate 5 Near Charter Way

Child Killed When Police Car Rear-Ends Sedan in Fatal Stockton Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.